Bard Avaulta Mesh Complications Lawsuits

Spread the love

Bard Avaulta mesh is a surgical implant used to correct pelvic organ prolapse and stress urinary incontinence in women. There are numerous risks associated with this device, and women may suffer from permanent side effects. As a result, a woman may need multiple surgeries and undergo extensive medical treatment to repair the damage caused by the mesh. Avaulta mesh complications lawsuits can help victims get the compensation they deserve.

Read On To Find Out More

Bard Avaulta mesh has been linked to serious side effects, including painful intercourse, infection, and pelvic pain. The FDA first issued a health advisory in 2008 warning consumers of these risks. The company also failed to properly research the product and establish its long-term efficacy. It also failed to provide adequate patient education. Ultimately, the company was fined for the lapses and recurrences and is working to improve the patient’s experience.

If mesh-related complications are discovered, patients may be given antibiotics. In severe cases, these antibiotics may be delivered through an intravenous infusion. However, the most effective treatment is surgical removal of the mesh and repair of any damaged tissue. Because the mesh is so delicate, surgical removal requires considerable skill. Because healthy tissue is often woven through a failing mesh, it must be carefully extracted to prevent further tissue damage. The extent of damage to tissue is not known until after surgery.

The FDA issued warnings for the Avaulta mesh in 2008 and 2011. The company then pulled the device from the market in 2012, resulting in litigation. In August 2013, a jury in California awarded plaintiff Donna Cisson $5 million and the nurse Wanda Queen $2 million. Both cases involved the Bard Avaulta mesh. As a result of these lawsuits, Bard has paid out millions of dollars in settlements.


Leave a Reply

Your email address will not be published. Required fields are marked *